Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126229411 | 12622941 | 1 | I | 2016 | 20160728 | 20160804 | 20160804 | EXP | US-UCBSA-2016028933 | UCB | 0.00 | F | Y | 70.00000 | KG | 20160804 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126229411 | 12622941 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 400 MG, EV 4 WEEKS, (STRENGTH: 200MG) | Y | U | 125160 | 400 | MG | ||||||
| 126229411 | 12622941 | 2 | C | Cyclafem | 2 | U | 0 | ||||||||||||
| 126229411 | 12622941 | 3 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126229411 | 12622941 | 4 | C | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | U | 0 | |||||||||||
| 126229411 | 12622941 | 5 | C | NORETHINDRONE. | NORETHINDRONE | 1 | U | 0 | |||||||||||
| 126229411 | 12622941 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 0 | |||||||||||
| 126229411 | 12622941 | 7 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126229411 | 12622941 | 1 | Crohn's disease |
| 126229411 | 12622941 | 2 | Product used for unknown indication |
| 126229411 | 12622941 | 3 | Product used for unknown indication |
| 126229411 | 12622941 | 4 | Product used for unknown indication |
| 126229411 | 12622941 | 5 | Product used for unknown indication |
| 126229411 | 12622941 | 6 | Product used for unknown indication |
| 126229411 | 12622941 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126229411 | 12622941 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126229411 | 12622941 | Anal abscess | |
| 126229411 | 12622941 | Diarrhoea | |
| 126229411 | 12622941 | Nasopharyngitis | |
| 126229411 | 12622941 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126229411 | 12622941 | 1 | 2011 | 2016 | 0 |